In addition, the discovery of the PDE5 inhibitor sildenafil in erectile dysfunction suggests that repurposing the existing entities is an effective strategy to accelerate the development of PDE inhibitors in cardiovascular diseases. This evidence concerns the gene PDE5A and erectile dysfunction.